Cotiviti nears $3 billion deal to acquire Edifecs, rejecting higher bid from UnitedHealth. Antitrust concerns cited.

KKR-backed healthcare data company Cotiviti is close to securing a deal to buy smaller rival Edifecs for just over $3bn, after it opted against accepting a higher bid from UnitedHealth Group out of ...

Cotiviti, a healthcare data company backed by KKR, is reportedly on the brink of finalizing a deal to acquire its smaller ...

In a report released today, Michael Cyprys from Morgan Stanley maintained a Hold rating on KKR & Co (KKR – Research Report), with a price ...

Evercore ISI analyst Glenn Schorr maintained a Buy rating on KKR & Co (KKR – Research Report) yesterday and set a price target of $165.00.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Plus, the food conglomerate owner of Krispy Kreme buys an insurance company and a distressed-debt battle in Japan ...

DOGE agents from Elon Musk's Department of Government Efficiency are investigating potential fraud and waste in Medicare.

Ratos AB Series B-2.41% kr11.59B ...